Colonial Trust Advisors’s GSK GSK Stock Holding History

Colonial Trust Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.5K	Hold	1,155	–	–	﹤0.01%	350
2026 Q1	$63.7K	Buy	1,155 +100	+9%	+$5.42K	0.01%	320
2025 Q4	$51.7K	Hold	1,055	–	–	﹤0.01%	341
2025 Q3	$45.5K	Hold	1,055	–	–	﹤0.01%	347
2025 Q2	$40.5K	Sell	1,055 -4,060	-79%	-$155K	﹤0.01%	369
2025 Q1	$198K	Buy	5,115 +3,868	+310%	+$142K	0.02%	203
2024 Q4	$42.2K	Hold	1,247	–	–	﹤0.01%	335
2024 Q3	$51K	Hold	1,247	–	–	﹤0.01%	332
2024 Q2	$48K	Hold	1,247	–	–	﹤0.01%	327
2024 Q1	$53.5K	Hold	1,247	–	–	0.01%	317
2023 Q4	$46.2K	Hold	1,247	–	–	﹤0.01%	325
2023 Q3	$45.2K	Hold	1,247	–	–	0.01%	337
2023 Q2	$44.4K	Hold	1,247	–	–	﹤0.01%	348
2023 Q1	$44.4K	Hold	1,247	–	–	0.01%	344
2022 Q4	$43.8K	Buy	+1,247	New	+$41.5K	0.01%	346

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Colonial Trust Advisors's GSK Position: Q2 2026 in Review

Colonial Trust Advisors held its GSK (GSK) position steady in Q2 2026 at 1,155 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Colonial Trust Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $198K in Q1 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Colonial Trust Advisors held 1,155 shares of GSK worth $60.5K as of Q2 2026.
Colonial Trust Advisors left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #350 holding.
Colonial Trust Advisors first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
Colonial Trust Advisors's GSK position peaked at $198K in Q1 2025.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.